CoChat
Sign Up
Cited by 33

The DOI matches its Crossref record.

RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis

Javorovic, Miran, Pohla, Heike, Frankenberger, Bernhard, Wölfel, Thomas, Schendel, Dolores J.·2005·Molecular Therapy
DOI 10.1016/j.ymthe.2005.03.034
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2005.03.034

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 33

  1. Clark, 1989, Model predicting survival in stage I melanoma based on tumor progression, J. Natl. Cancer. Inst., 8, 1893, 10.1093/jnci/81.24.1893 · DOI
  2. Clemente, 1996, Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, Cancer, 77, 1303, 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 · DOI
  3. Dudley, 2002, Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, 298, 850, 10.1126/science.1076514 · DOI · Paper page
  4. Ramirez-Montagut, 2003, Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity, Oncogene, 22, 3180, 10.1038/sj.onc.1206462 · DOI
  5. Wolfel, 1995, A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, Science, 269, 1281, 10.1126/science.7652577 · DOI
  6. Cerundolo, 2004, Dendritic cells: a journey from laboratory to clinic, Nat. Immunol., 5, 7, 10.1038/ni0104-7 · DOI
  7. Schuler, 2003, The use of dendritic cells in cancer immunotherapy, Curr. Opin. Immunol., 15, 138, 10.1016/S0952-7915(03)00015-3 · DOI
  8. Steinman, 2002, Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance, Proc. Natl. Acad. Sci. USA, 99, 351, 10.1073/pnas.231606698 · DOI
  9. Lutz, 2002, Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?, Trends Immunol., 23, 445, 10.1016/S1471-4906(02)02281-0 · DOI
  10. Jager, 2002, Clinical cancer vaccine trials, Curr. Opin. Immunol., 14, 178, 10.1016/S0952-7915(02)00318-7 · DOI
  11. Boczkowski, 1996, Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo, J. Exp. Med., 184, 465, 10.1084/jem.184.2.465 · DOI · Paper page
  12. Heiser, 2002, Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors, J. Clin. Invest., 109, 409, 10.1172/JCI0214364 · DOI · Paper page
  13. Su, 2003, Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells, Cancer Res., 63, 2127
  14. Bonehill, 2004, Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules, J. Immunol., 172, 6649, 10.4049/jimmunol.172.11.6649 · DOI
  15. Eppler, 2002, Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA, Eur. J. Cancer, 38, 184, 10.1016/S0959-8049(01)00342-2 · DOI
  16. Liao, 2004, Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes, Mol. Ther., 9, 757, 10.1016/j.ymthe.2004.02.011 · DOI
  17. Wherry, 1999, The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained, J. Immunol., 163, 3735, 10.4049/jimmunol.163.7.3735 · DOI
  18. Tsien, 1998, The green fluorescent protein, Annu. Rev. Biochem., 67, 509, 10.1146/annurev.biochem.67.1.509 · DOI
  19. Li, 1998, Generation of destabilized green fluorescent protein as a transcription reporter, J. Biol. Chem., 273, 34970, 10.1074/jbc.273.52.34970 · DOI · Paper page
  20. Morel, 2000, Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells, Immunity, 12, 107, 10.1016/S1074-7613(00)80163-6 · DOI
  21. Velculescu, 1999, Analysis of human transcriptomes, Nat. Genet., 23, 387, 10.1038/70487 · DOI
  22. Johansson, 2002, Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines, Melanoma Res., 12, 193, 10.1097/00008390-200206000-00002 · DOI
  23. Ashley, 1997, Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors, J. Exp. Med., 186, 1177, 10.1084/jem.186.7.1177 · DOI
  24. Boczkowski, 2000, Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells, Cancer Res., 60, 1028
  25. Mumberg, 1996, Unique tumor antigens redefined as mutant tumor-specific antigens, Semin. Immunol., 8, 289, 10.1006/smim.1996.0037 · DOI
  26. Rivoltini, 1995, Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes, Cancer Res., 55, 3149
  27. Riker, 2000, Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes, Int. J. Cancer., 86, 818, 10.1002/(SICI)1097-0215(20000615)86:6<818::AID-IJC10>3.0.CO;2-W · DOI
  28. Salter, 1985, Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids, Immunogenetics, 21, 235, 10.1007/BF00375376 · DOI
  29. Visseren, 1995, CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells, J. Immunol., 154, 3991, 10.4049/jimmunol.154.8.3991 · DOI
  30. Noessner, 2002, Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells, J. Immunol., 169, 5424, 10.4049/jimmunol.169.10.5424 · DOI
  31. Wolfel, 2000, Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope, Int. J. Cancer, 88, 432, 10.1002/1097-0215(20001101)88:3<432::AID-IJC16>3.0.CO;2-9 · DOI
  32. Nair, 1998, Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA, Nat. Biotechnol., 16, 364, 10.1038/nbt0498-364 · DOI
  33. Heiser, 2001, Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA, J. Immunol., 166, 2953, 10.4049/jimmunol.166.5.2953 · DOI

Cited by

Sorted by citations

See all 33

Metadata

Authors
Javorovic, M., Pohla, H., Frankenberger, B., Wölfel, T., & Schendel, D. J.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2005-10
Volume
12
Issue
4
Pages
734-743
ISSN
1525-0016
DOI
10.1016/j.ymthe.2005.03.034
Cited by
33
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis. https://app.cochat.ai/papers/10.1016/j.ymthe.2005.03.034
The paper
Javorovic, M., Pohla, H., Frankenberger, B., Wölfel, T., & Schendel, D. J. (2005). RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2005.03.034